The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
NCT06333080 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2026-04-21
Summary
The objective of the trial is to investigate the effect of adherence to oral semaglutide dosing instructions on glycaemic control in people with type 2 diabetes, which are dysregulated on metformin and naïve to second line antidiabetic treatment.
Conditions
- Diabetes Mellitus, Type 2
Sponsors & Collaborators
-
Aalborg University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2025-07-29
- Completion
- 2025-07-29
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
NCT01930188 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
NCT02254291 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
NCT02849080 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
NCT03191396 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
NCT06339086 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
NCT05303857 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
NCT02016911 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
NCT03989232 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
NCT04707469 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
NCT05144984 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
NCT04017832 ·Status: COMPLETED ·Phase: PHASE3
-
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
NCT05755360 ·Status: COMPLETED
-
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
NCT04097600 ·Status: COMPLETED ·Phase: PHASE1
-
Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
NCT06659679 ·Status: COMPLETED
-
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
NCT03929679 ·Status: COMPLETED
-
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
NCT02022254 ·Status: COMPLETED ·Phase: PHASE1
-
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
NCT07056803 ·Status: COMPLETED
-
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
NCT04067999 ·Status: COMPLETED
-
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
NCT03175120 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
NCT02054897 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
NCT07195994 ·Status: RECRUITING ·Phase: NA
-
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
NCT02070510 ·Status: COMPLETED ·Phase: PHASE1
-
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
NCT01937598 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
NCT06351748 ·Status: COMPLETED
-
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
NCT00700817 ·Status: COMPLETED ·Phase: PHASE3